SPERMATOZOA PROGRESSIVE MOTILITY DECREASED

SPERMATOZOA PROGRESSIVE MOTILITY DECREASED was reported 169 times

These drug classes are most commonly taken by patients reporting SPERMATOZOA PROGRESSIVE MOTILITY DECREASED:

# Drug Count
0 5-alpha Reductase Inhibitor [EPC] 29
1 Corticosteroid [EPC] 17
2 Anti-epileptic Agent [EPC] 13
3 Calcineurin Inhibitor Immunosuppressant [EPC] 12
4 Mood Stabilizer [EPC] 12
5 Nonsteroidal Anti-inflammatory Drug [EPC] 12
6 beta-Adrenergic Blocker [EPC] 10
7 Alkaloid [EPC] 9
8 Antimycobacterial [EPC] 8
9 Atypical Antipsychotic [EPC] 8
10 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 8
11 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 8
12 HMG-CoA Reductase Inhibitor [EPC] 7
13 Platelet Aggregation Inhibitor [EPC] 7
14 Purine Antimetabolite [EPC] 7
15 Non-Standardized Food Allergenic Extract [EPC] 5
16 Non-Standardized Plant Allergenic Extract [EPC] 5
17 Vitamin B12 [EPC] 5
18 Vitamin C [EPC] 5
19 Vitamin D [EPC] 5
20 Benzodiazepine [EPC] 4
21 Folate Analog Metabolic Inhibitor [EPC] 4
22 Kinase Inhibitor [EPC] 3
23 Serotonin Reuptake Inhibitor [EPC] 3
24 Tumor Necrosis Factor Blocker [EPC] 3
25 Angiotensin 2 Receptor Blocker [EPC] 2
26 Arteriolar Vasodilator [EPC] 2
27 Azole Antifungal [EPC] 2
28 CD20-directed Cytolytic Antibody [EPC] 2
29 Recombinant Human Growth Hormone [EPC] 2
30 mTOR Inhibitor Immunosuppressant [EPC] 2
31 Aldosterone Antagonist [EPC] 1
32 Aminosalicylate [EPC] 1
33 Anti-IgE [EPC] 1
34 Antimetabolite Immunosuppressant [EPC] 1
35 Antimetabolite [EPC] 1
36 Cholinergic Nicotinic Agonist [EPC] 1
37 Dihydropyridine Calcium Channel Blocker [EPC] 1
38 Endothelin Receptor Antagonist [EPC] 1
39 Interleukin-17A Antagonist [EPC] 1
40 Loop Diuretic [EPC] 1
41 Opioid Agonist [EPC] 1
42 Partial Opioid Agonist [EPC] 1
43 Proton Pump Inhibitor [EPC] 1
44 Retinoid [EPC] 1
45 Topoisomerase Inhibitor [EPC] 1
46 alpha-Adrenergic Blocker [EPC] 1